Concepedia

Publication | Closed Access

Multicenter, Randomized, Phase III Study of a Single Dose of IncobotulinumtoxinA, Free from Complexing Proteins, in the Treatment of Glabellar Frown Lines

DOI

67

Citations

10

References

2013

Year

Alastair Carruthers, Jean Carruthers, William P. Coleman, Lisa Donofrio, Timothy C. Flynn, Michael H. Gold, Moritz Heinz, Laura Harrington, Derek Jones, David H. McDaniel,
Dermatologic Surgery

Abstract

A single dose of 20 U of incobotulinumtoxinA demonstrated efficacy and safety in the treatment of glabellar frown lines using new Food and Drug Administration efficacy variables.

References

YearCitations

Page 1